Home
Ind-swift Laboratories Ltd EPS

Ind-Swift Laboratories Ltd
NSE: INDSWFTLAB
EPS
Key Highlights
- The Earning per Share of Ind-Swift Laboratories Ltd is ₹ 14 as of 21 Feb 25 .
- The earning per share of Ind-Swift Laboratories Ltd changed from ₹ 2.92 to ₹ 0 over 7 quarters. This represents a CAGR of -100.00% .
Historical Earning per Share of Ind-Swift Laboratories Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Ind-Swift Laboratories Ltd
Company Fundamentals for Ind-Swift Laboratories Ltd
Market Cap
554 Cr
EPS
14.0
P/E Ratio (TTM)
6.7
P/B Ratio (TTM)
0.6
Day’s High
94.35
Day’s Low
88.85
DTE
0.0
ROE
10.1
52 Week High
186.0
52 Week Low
85.6
ROCE
13.3
Market Price of Ind-Swift Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 93.8 |
20 Feb 2025 | 89.25 |
19 Feb 2025 | 89.05 |
18 Feb 2025 | 90.2 |
17 Feb 2025 | 95.1 |
14 Feb 2025 | 92.5 |
13 Feb 2025 | 92.05 |
12 Feb 2025 | 91.9 |
11 Feb 2025 | 94.95 |
10 Feb 2025 | 98.35 |
SWOT Analysis Of Ind-Swift Laboratories Ltd
BlinkX Score for Ind-Swift Laboratories Ltd
Asset Value vs Market Value of Ind-Swift Laboratories Ltd
Market Value
₹ 554
-0.2 X
Value addition
Asset Value
₹ 693
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Ind-Swift Laboratories Ltd | 554.23 | 14 |
Sun Pharmaceuticals Industries Ltd | 394223 | 49.16 |
Divis Laboratories Ltd | 152610 | 77.86 |
Cipla Ltd | 119067 | 61.78 |
Torrent Pharmaceuticals Ltd | 102739 | 55.02 |
Dr Reddys Laboratories Ltd | 96124 | 64.37 |
Company | |
---|---|
Ind-Swift Laboratories Ltd | 554.23 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
Historical Market Cap of Ind-Swift Laboratories Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Ind-Swift Laboratories Ltd
Historical Revenue of Ind-Swift Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Ind-Swift Laboratories Ltd
Historical EBITDA of Ind-Swift Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Ind-Swift Laboratories Ltd
Historical Net Profit of Ind-Swift Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Ind-Swift Laboratories Ltd
Dividend Payout Over Time
Ind-Swift Laboratories Ltd News Hub
Ind-Swift Laboratories consolidated net profit declines 94.55% in the June 2024 quarter
Net profit of Ind-Swift Laboratories declined 94.55% to Rs 0.94 crore in the quarter ended June 2024
Read more
13 Aug 24
Ind-Swift Laboratories standalone net profit declines 63.70% in the June 2024 quarter
Net profit of Ind-Swift Laboratories declined 63.70% to Rs 6.19 crore in the quarter ended June 2024
Read more
13 Aug 24
Ind-Swift Laboratories to discuss results
Ind-Swift Laboratories will hold a meeting of the Board of Directors of the Company on 12 August 202
Read more
03 Aug 24
Ind-Swift Laboratories to hold AGM
Ind-Swift Laboratories announced that the Annual General Meeting (AGM) of the company will be held o
Read more
03 Sept 24